2,053 research outputs found
Prevalence of Rabbit Hemorrhagic Disease (RHD) in wild rabbits (Oryctolagus cuniculus) in Flanders, Belgium, 1999-2002
During the period of July 1999 through June 2002, carcasses of wild rabbits that had been shot or found dead and livers originating from wild rabbits that had been shot for consumption were collected in Flanders. One hundred and twelve carcasses were suitable for necropsy and histological and bacteriological analysis; histological analysis was possible in 41 livers. Considering the 112 rabbit carcasses only, Rabbit Hemorrhagic Disease (RHD) was found to be present in 33.9% of the cases. RHD was the most prevalent wild rabbit pathology detected in this study, before staphylococcosis (12.5%), and myxomatosis (10.7%). None of the liver samples from rabbits shot for consumption were positive for RHD. Of the 38 histologically RHD positive samples, 24 were analyzed with the hemagglutination (HA) technique, yielding 58.3% positive results. Seven samples that were histologically positive for RHD but HA negative were examined by transmission electron microscopy and were found positive for calicivirus. This proves that HA-negative RHD strains are circulating in the Flemish wild rabbit population
Promoting rural competitiveness – how can "organic" and "regional" accelerate development in poorer areas?
As consumers’ interest for quality food grows, new opportunities arise for both organic and regional products. This is especially appealing for rural areas with a strong agricultural tradition. Yet, to be successful, such initiatives require a sound methodological approach to analyse well the context and opportunities together with different stakeholders and develop a marketing strategy that overcomes both market- and supply-oriented constraints
Understanding the role of long-acting muscarinic antagonists in asthma treatment
Objective: Long-acting muscarinic antagonists (LAMAs) have been used in the treatment of obstructive pulmonary diseases for years. Long-acting muscarinic antagonists were previously mainly used as bronchodilators in chronic obstructive pulmonary disease, but the use of LAMAs in the treatment of asthma has gained great interest. There is now ample evidence of the efficacy and safety of LAMAs as add-on therapy to inhaled corticosteroid (ICS) plus long-acting β 2-agonist (LABA) combinations in patients with moderate to severe uncontrolled asthma. Long-acting muscarinic antagonists have subsequently been included in asthma guidelines. This review summarizes the scientific evidence on the use of LAMAs in asthma and aims to provide a better understanding of the role of LAMAs in the asthma treatment care algorithm and the current gaps in our knowledge. Data sources: PubMed review using the following words: long-acting muscarinic antagonists, asthma, muscarinic receptors, tiotropium, glycopyrronium, umeclidinium. Study selections: This review focused on the key trials that led to the inclusion of LAMAs in asthma guidelines. In addition, we highlighted a number of studies with other study designs and populations. Results: We identified 6 major studies that led to inclusion in asthma guidelines and 3 studies with other study designs and populations. Conclusion: Long-acting muscarinic antagonists add-on therapy to ICS-LABA improves lung function, reduces exacerbations, and modestly improves asthma control in patients with moderate to severe asthma who are uncontrolled despite the use of ICS-LABA. Long-acting muscarinic antagonists are effective in all asthma phenotypes and endotypes
Cardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in COPD history
SUMMIT supports the efficiency and cardiovascular safety of LABA and ICS in COPD patients at cardiovascular risk http://ow.ly/p6Is300ffoc
Psoas abscess: report of a series and review of the literature
We describe a series of twelve patients with a psoas abscess seen in a
three-year period in a university hospital and a large teaching hospital
in the Netherlands. In our series, five of the 12 patients had a primary
psoas abscess. The predisposing conditions were intravenous drug use,
diabetes mellitus, prostate carcinoma and haematoma in the psoas muscle in
a patient with haemophilia A. Seven of the 12 patients had a secondary
psoas abscess. Five cases were due to vertebral osteomyelitis including
two cases of tuberculosis. In the other two cases it was due to colitis
and urinary tract infection. It is remarkable that in our series there was
only one patient with a psoas abscess secondary to a disease of the
digestive tract, while this is the most common cause of a secondary psoas
abscess in the literature. There were two cases of tuberculosis which is
an emerging disease again
Sputum microbiome profiling in COPD: beyond singular pathogen detection.
Culture-independent microbial sequencing techniques have revealed that the respiratory tract harbours a complex microbiome not detectable by conventional culturing methods. The contribution of the microbiome to chronic obstructive pulmonary disease (COPD) pathobiology and the potential for microbiome-based clinical biomarkers in COPD are still in the early phases of investigation. Sputum is an easily obtainable sample and has provided a wealth of information on COPD pathobiology, and thus has been a preferred sample type for microbiome studies. Although the sputum microbiome likely reflects the respiratory microbiome only in part, there is increasing evidence that microbial community structure and diversity are associated with disease severity and clinical outcomes, both in stable COPD and during the exacerbations. Current evidence has been limited to mainly cross-sectional studies using 16S rRNA gene sequencing, attempting to answer the question 'who is there?' Longitudinal studies using standardised protocols are needed to answer outstanding questions including differences between sputum sampling techniques. Further, with advancing technologies, microbiome studies are shifting beyond the examination of the 16S rRNA gene, to include whole metagenome and metatranscriptome sequencing, as well as metabolome characterisation. Despite being technically more challenging, whole-genome profiling and metabolomics can address the questions 'what can they do?' and 'what are they doing?' This review provides an overview of the basic principles of high-throughput microbiome sequencing techniques, current literature on sputum microbiome profiling in COPD, and a discussion of the associated limitations and future perspectives
High miR203a-3p and miR-375 expression in the airways of smokers with and without COPD
Smoking is a leading cause of chronic obstructive pulmonary disease (COPD). It is known to have a significant impact on gene expression and (inflammatory) cell populations in the airways involved in COPD pathogenesis. In this study, we investigated the impact of smoking on the expression of miRNAs in healthy and COPD individuals. We aimed to elucidate the overall smoking-induced miRNA changes and those specific to COPD. In addition, we investigated the downstream effects on regulatory gene expression and the correlation to cellular composition. We performed a genome-wide miRNA expression analysis on a dataset of 40 current- and 22 ex-smoking COPD patients and a dataset of 35 current- and 38 non-smoking respiratory healthy controls and validated the results in an independent dataset. miRNA expression was then correlated with mRNA expression in the same patients to assess potential regulatory effects of the miRNAs. Finally, cellular deconvolution analysis was used to relate miRNAs changes to specific cell populations. Current smoking was associated with increased expression of three miRNAs in the COPD patients and 18 miRNAs in the asymptomatic smokers compared to respiratory healthy controls. In comparison, four miRNAs were lower expressed with current smoking in asymptomatic controls. Two of the three smoking-related miRNAs in COPD, miR-203a-3p and miR-375, were also higher expressed with current smoking in COPD patients and the asymptomatic controls. The other smoking-related miRNA in COPD patients, i.e. miR-31-3p, was not present in the respiratory healthy control dataset. miRNA-mRNA correlations demonstrated that miR-203a-3p, miR-375 and also miR-31-3p expression were negatively associated with genes involved in pro-inflammatory pathways and positively associated with genes involved in the xenobiotic pathway. Cellular deconvolution showed that higher levels of miR-203a-3p were associated with higher proportions of proliferating-basal cells and secretory (club and goblet) cells and lower levels of fibroblasts, luminal macrophages, endothelial cells, B-cells, amongst other cell types. MiR-375 expression was associated with lower levels of secretory cells, ionocytes and submucosal cells, but higher levels of endothelial cells, smooth muscle cells, and mast cells, amongst other cell types. In conclusion, we identified two smoking-induced miRNAs (miR-375 and miR-203a-3p) that play a role in regulating inflammation and detoxification pathways, regardless of the presence or absence of COPD. Additionally, in patients with COPD, we identified miR-31-3p as a miRNA induced by smoking. Our identified miRNAs should be studied further to unravel which smoking-induced inflammatory mechanisms are reactive and which are involved in COPD pathogenesis
Insights into the mechanism of MCT8 oligomerization
Mutations in the thyroid hormone transporter monocarboxylate transporter 8 (MCT8) result in MCT8 deficiency, characterized by severe intellectual and motor disability. The MCT8 protein is predicted to have 12 transmembrane domains (TMDs) and is expressed as monomers, homodimers, and homo-oligomers. This study aimed to delineate the mechanism o
Biomass increment and carbon sequestration in hedgerow-grown trees
The global role of tree-based climate change mitigation is widely recognized; trees sequester large amounts of atmospheric carbon, and woody biomass has an important role in the future biobased economy. In national carbon and biomass budgets, trees growing in hedgerows and tree rows are often allocated the same biomass increment data as forest-grown trees. However, the growing conditions in these linear habitats are different from forests given that the trees receive more solar radiation, potentially benefit from fertilization residuals from adjacent fields and have more physical growing space. Tree biomass increment and carbon storage in linear woody elements should therefore be quantified and correctly accounted for. We examined four different hedgerow systems with combinations of pedunculate oak, black alder and silver birch in northern Belgium. We used X-ray CT scans of pith-to-bark cores of 73 trees to model long-term (tree life span) and short-term (last five years) trends in basal area increment and increment in aboveground stem biomass. The studied hedgerows and tree rows showed high densities (168–985 trees km-1) and basal areas (22.1–44.9 m2 km-1). In all four hedgerow systems, we found a strong and persistent increase in stem biomass and thus carbon accumulation with diameter (long-term trend). The current growth performance (short-term trend) also increased with tree diameter and was not related to hedgerow tree density or basal area, which indicates that competition for light does not (yet) limit tree growth in these ecosystems. The total stem volume was 82.0–339.7 m3 km-1 (corresponding to 18.8–100.7 Mg aboveground carbon km-1) and the stem volume increment was 3.1–14.5 m3 km-1 year-1 (aboveground carbon sequestration 0.7–4.3 Mg km-1 year-1). The high tree densities and the persistent increase in growth of trees growing in hedgerow systems resulted in substantial wood production and carbon sequestration rates at the landscape scale. Our findings show that trees growing in hedgerow systems should be included when biomass and carbon budgets are drafted. The biomass production rates of hedgerow trees we provide can help refine the IPCC Guidelines for National Greenhouse Gas Inventories
- …